✦ LIBER ✦

Histone Deacetylase Inhibitors and Bladder Cancer

✍ Scribed by Adam, Rosalyn M.

Book ID: 123395281
Publisher: Lippincott Williams and Wilkins
Year: 2010
Tongue: English
Weight: 102 KB
Volume: 183
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2010.03.047

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Experimental study on inhibitory effects

Experimental study on inhibitory effects of histone deacetylase inhibitor MS-275 and TSA on bladder cancer cells

✍ Wei Qu; Yin-dong Kang; Mei-sheng Zhou; Li-li Fu; Zhen-hao Hua; Li-ming Wang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 895 KB

The histone deacetylase inhibitor belino

The histone deacetylase inhibitor belinostat (PXD101) suppresses bladder cancer cell growth in vitro and in vivo

✍ Michael T Buckley; Joanne Yoon; Herman Yee; Luis Chiriboga; Leonard Liebes; Guls 📂 Article 📅 2007 🏛 BioMed Central 🌐 English ⚖ 991 KB

1358 NANOPARTICLE DELIVERY OF THE HISTON

1358 NANOPARTICLE DELIVERY OF THE HISTONE DEACETYLASE INHIBITOR PXD101 FACILITATES BLADDER CANCER CELL UPTAKE AND CYTOTOXICITY

✍ Kaimakliotis, Hristos Z.; Martin, Darryl T.; Hoimes, Christopher J.; Cheng, Chri 📂 Article 📅 2011 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 110 KB

MODULATION OF CD44-EXPRESSING BLADDER CA

MODULATION OF CD44-EXPRESSING BLADDER CANCER CELLS BY HISTONE DEACETYLASE INHIBITORS: INCREASING THE EFFICACY OF CHEMO-RADIATION?

✍ Kao, Gary D; Dowling, Melissa L; Malkowicz, S Bruce 📂 Article 📅 2008 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 124 KB

The use of histone deacetylase inhibitor

The use of histone deacetylase inhibitor FK228 and DNA hypomethylation agent 5-azacytidine in human bladder cancer therapy

✍ Jose A. Karam; Jinhai Fan; Jennifer Stanfield; Edmond Richer; Elie A. Benaim; Eu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 French ⚖ 811 KB

## Abstract The long‐term disease‐free survival in patients with metastatic transitional cell carcinoma (TCC) is still considerably low. Novel chemotherapeutic agents are needed to decrease the morbidity and mortality of TCC. In this study, we have evaluated several epigenetic modifiers for their t

Gene expression profiling of KBH-A42, a

Gene expression profiling of KBH-A42, a novel histone deacetylase inhibitor, in human leukemia and bladder cancer cell lines

✍ Park, Song-Kyu 📂 Article 📅 2011 🏛 Spandidos Publications 🌐 English ⚖ 489 KB